Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling.

Journal of gynecologic oncology - 1 May 2020

Chao Angel, Lin Yi Hao, Yang Lan Yan, Wu Ren Chin, Chang Wei Yang, Chang Pi Yueh, Chang Shih Cheng, Lin Chiao Yun, Huang Huei Jean, Lin Cheng Tao, Chou Hung Hsueh, Huang Kuan Gen, Kuo Wen Ling, Chang Ting Chang, Lai Chyong Huey

Abstract excerpt

OBJECTIVE: The characteristics of patients with metachronous breast and ovarian malignancies and the pathogenic role of BRCA1/2 mutations remain poorly understood. We investigated these issues through a review of hospital records and nationwide Taiwanese registry data, followed by BRCA1/2 mutation analysis in hospital-based cases. METHODS: We retrospectively retrieved consecutive clinical records of Taiwanese...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genetic Counseling

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Share to Taiwan

Source

Open in PubMed Open full text

Identifiers

PMID: 31912679
DOI: 10.3802/jgo.2020.31.e24
PMCID: PMC7189074

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling.PMID 31912679Read ↗

Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.Semantic proximity Read ↗

Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations.Semantic proximity Read ↗

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian CancerSemantic proximity Read ↗

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer.Semantic proximity Read ↗

Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration.Semantic proximity Read ↗

Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.Semantic proximity Read ↗

Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer.Semantic proximity Read ↗

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.Semantic proximity Read ↗

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer.Semantic proximity Read ↗

Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer.Semantic proximity Read ↗

Germline breast cancer susceptibility gene mutations and breast cancer outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.